🔗 Share this article

Chancellor Reeves has stated she is planning "focused measures to deal with cost of living issues" in next month's financial statement.

In comments to the BBC, she stated that lowering inflation is a shared task of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Measures

Reports indicate the government could take action to bring down utility costs, for instance by cutting the present 5% rate of value-added tax applied on energy supplies.

Another possibility is to reduce some of the government charges presently included in household expenses.

Fiscal Limitations and Analyst Expectations

The administration will receive the latest report from the official forecaster, the OBR, on Monday, which will clarify how much scope there is for these actions.

The consensus from most economists is that the Chancellor will have to declare higher taxes or spending cuts in order to adhere to her self-imposed borrowing rules.

Earlier on the same day, calculations suggested there was a £22bn gap for the Treasury chief to resolve, which is at the more modest range of expectations.

"It is a shared responsibility between the Bank of England and the administration to continue tackling some of the drivers of inflation," the Chancellor stated to reporters in the US capital, at the annual meetings of the IMF and World Bank.

Revenue Pledges and Global Issues

While a great deal of the attention has been on expected tax increases, the chancellor said the most recent figures from the OBR had not altered her pledge to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "uncertain world" with rising geopolitical and trade concerns for the Budget tax moves, likely to be directed on those "most able to pay."

International Economic Disputes

Commenting on concerns about the UK's trade ties with the Asian nation she said: "Our security interests always are paramount."

Recent announcement by China to tighten export controls on rare earths and other resources that are essential for advanced tech production led American leader the US President to propose an additional 100% import tax on goods from China, increasing the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief described China's move "economic coercion" and "a global supply chain power grab."

Asked about accepting the American proposal to join its dispute with China, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and generates additional challenges."

"In my view there are sectors where we should address Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other areas of the economy. We've got to maintain that balance correct."

The chancellor also confirmed she was collaborating with G7 counterparts "on our own critical minerals approach, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the cost the National Health Service pays for pharmaceuticals could increase as a result of ongoing talks with the Trump administration and its drugs companies, in return for reduced taxes and capital.

Some of the biggest global drug companies have said lately that they are either halting or abandoning operations in the United Kingdom, with several attributing the insufficient payments they are obtaining.

Recently, the government science advisor said the price the NHS pays for drugs would must increase to prevent businesses and drug research funding departing from the United Kingdom.

The Chancellor stated to the BBC: "We have seen due to the cost structure, that clinical trials, innovative medicines have not been provided in the United Kingdom in the extent that they are in other continental states."

"We want to make sure that people getting care from the National Health Service are can receive the best life-saving drugs in the globe. And so we are examining this situation, and... seeking to secure more investment into the UK."